基于(关键地区、市场参与者、规模和份额)的中型制药市场 - 到 2031 年的预测

  • Report Code : TIPRE00018321
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 203
Buy Now

中型制药市场预计将从 2022 年的 6901.052 亿美元增长到 2028 年的 10005.843 亿美元;预计 2022 年至 2028 年复合年增长率为 6.4%。

收入、治疗领域、研发支出和覆盖范围是全球制药行业的关键部分。中型制药属于制药行业的三类之一。它强调仿制药的开发和罕见疾病疗法的开发。中型制药公司的收入在10亿美元至100亿美元之间。慢性病患病率不断上升、老年人口迅速增加以及产品上市和批准数量激增预计将有助于中型制药市场的增长。

该报告提供了以下见解和深入分析:中型制药市场,强调市场趋势、技术进步和市场动态等各种参数。它还提供了主要市场参与者的竞争格局分析以及 COVID-19 大流行对所有主要地区市场的影响。 COVID-19 大流行影响了全球经济的三个主要方面——制造业、供应链和金融市场。然而,疫情对中型医药市场的影响最初是负面的,后来转为正面的。在 COVID-19 大流行之初,这些地区的中型制药市场面临着众多短期和长期挑战,包括对生产和需求的直接影响、对制造公司的财务影响以及供应链和供应链的中断。市场。在中型制药市场,疫情的影响几乎是可以预测的。结果是对患者护理和治疗所必需的产品的需求和资金极高,例如传染病、呼吸道疾病、糖尿病和流感疫苗。然而,非必需药物的预算有限或无法获得。

战略见解

由于各地区试验管理方式迅速改变,大多数地区都可以根据客户的需求提供临床试验服务。需要。生物技术公司目前正在这些地区启动临床试验。自疫情爆发以来,亚太地区的局势有所改善。截至 2020 年 5 月,97% 的站点重新开放供患者就诊,83% 的站点开放供 CRA 现场就诊。此外,与往年相比,中国医院的住院/门诊开放率高达90%。此外,临床中心也正在恢复正常运营。

按地区划分,中型制药市场分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。

中型制药市场利润丰厚的地区

市场洞察
慢性病患病率的增加推动中型制药市场

市场洞察h3>

人口老龄化和社会行为的变化导致常见且代价高昂的长期健康问题稳步增加。随着城市化进程的加快,人们开始采取久坐的生活方式,这增加了肥胖率和糖尿病等疾病的发病率。据世界卫生组织预测,到2026年,慢性病患病率预计将增加57%。由于慢性病发病率上升,对医疗保健系统的需求不断增加已成为一个主要问题。例如,根据国际糖尿病联盟(IDF)的数据,2019年北美糖尿病患者人数约为4600万,预计到2045年将增加到6200万。2019年,疾病患病率将增加约35%。预测的时期。流行病对健身系统产生周期性和巨大的破坏性压力。世界各地的医疗机构希望做好准备,在疫情爆发后共同遏制疫情。因此,慢性病患病率的增加促进了中型药品市场的增长。

基于类型的见解

根据类型,中型药品市场分为处方药和处方药。在柜台。 2022年,场外交易领域占据更大的市场份额。预计它将成为增长最快的细分市场之一。该细分市场的市场增长归因于制药公司用于药品营销的预算分配增加以及可支配收入的增加。

中型制药市场(按类型) 2022年和2028年

基于药物开发类型的见解

根据药物开发类型,中型制药市场分为内部和外包。到 2022 年,外包细分市场将占据更大的市场份额。对合同开发和制造组织 (CDMO) 的需求不断增加,以及市场新进入者数量的增加,将推动预测期内外包细分市场的市场增长。

基于配方的见解

根据配方,中型制药市场分为片剂和片剂。胶囊、注射剂、喷雾剂和其他制剂。平板电脑和胶囊细分市场在 2022 年占据最大的市场份额。片剂和胶囊在长期治疗中的广泛使用、喷雾剂的简便使用以及创新的注射制剂(例如预充式注射器和固定剂量注射器)预计将推动市场的增长对于平板电脑和预测期内的胶囊细分市场。

基于治疗类别的见解

根据治疗类别,中型制药市场分为心血管疾病、疼痛管理、糖尿病、癌症、及其他条件。到2022年,糖尿病细分市场占据最大的市场份额。由于慢性病患病率上升和癌症发病率不断上升,预计癌症细分市场在预测期内将快速增长。

中型制药市场参与者正在采用有机和无机战略,包括产品推出和扩张,以扩大其全球足迹和产品组合。第一三共有限公司;卫材有限公司;再生元制药公司;博士健康公司;太阳制药工业有限公司;亚力兄制药公司;马林克罗特;远藤制药公司;施维雅实验室;和 UCB SA 是中型制药市场的领先公司。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are the top companies that hold the market share in mid-size pharmaceuticals market?

DAIICHI SANKYO COMPANY LIMITED and Regeneron Pharmaceuticals, Inc, are the top two companies that hold huge market shares in the mid-size pharmaceuticals market.

Who are the key players in the mid-size pharmaceuticals market?

The mid-size pharmaceuticals market majorly consists of players such as DAIICHI SANKYO COMPANY LIMITED, Eisai Co., Ltd., Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Alexion Pharmaceuticals, Inc., Mallinckrodt, Endo Pharmaceuticals Inc., Les Laboratories Servier, UCB S.A. amongst others.

Which drug development type held the largest share in the mid-size pharmaceuticals market?

In 2021, the hip outsource held the largest share of the market, by drug development type. It is expected to report a higher CAGR of 6.7% during 2021–2028.

Which type led the mid-size pharmaceuticals market?

In 2021, the over-the-counter segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The major driving factors for the growth of the over-the-counter segment are increasing budget allocation by pharmaceutical companies for the marketing of drugs, higher disposable income, and the rising prevalence of chronic diseases. Moreover, the increasing self-medication tendency among the population is one of the significant factors in the growth of the over-the-counter (OTC) segment.

What is the market CAGR value of the mid-size pharmaceuticals market during the forecast period?

The CAGR value of the mid-size pharmaceuticals market during the forecasted period of 2021–2028 is 6.4%.

What are the driving factors for the mid-size pharmaceuticals market across the globe?

Key factors that are driving the growth of this market are the growing prevalence of prevalence of chronic disorders and rising number of product launches and approvals are expected to drive the market during the forecast period.

What is mid-size pharmaceutical?

Mid-size pharmaceutical is among the three categories of pharmaceutical industry. The global pharmaceutical industry is segmented on the basis of their revenue, therapy area, R&D expenditure, reach etc. The mid-sized pharmaceutical companies are those companies which have their revenue in range of US$ 1 billion to US$ 10 billion. Mid-size pharmaceutical emphasizes on generic drug and development of rare disease therapies.

The List of Companies - Mid-Size Pharmaceutical Market

  1. DAIICHI SANKYO COMPANY LIMITED
  2. Eisai Co., Ltd.
  3. Bausch Health Companies Inc.
  4. Regeneron Pharmaceuticals, Inc
  5. Sun Pharmaceutical Industries Ltd
  6. Alexion Pharmaceuticals, Inc.
  7. Mallinckrodt
  8. Endo Pharmaceuticals Inc.
  9. Les Laboratories Servier
  10. UCB S.A.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports